Vol 60, No 2 (2022)
Original paper
Published online: 2022-06-22

open access

Page views 4618
Article views/downloads 635
Get Citation

Connect on Social Media

Connect on Social Media

MIR4435-2HG, miR-125b-5p, and Sema4D axis affects the aggressiveness of colorectal cancer cells

Ming Yu1, Zhengguo Yi1, Shenghui Chen1, Xiaopeng Chen1, Xiaofeng Xie1
Pubmed: 35730423
Folia Histochem Cytobiol 2022;60(2):191-202.

Abstract

Introduction. The purpose of this study is to elucidate the impact of long non-coding RNA (lncRNA) MIR4435-2HG/microRNA (miR)-125b-5p/ Semaphorins 4D (Sema4D) on colorectal cancer (CRC) cell propagation and migration.
Material and methods. Sema4D expression in 73 pairs of CRC tissues and matched adjacent normal tissues was measured by qRT-PCR and western blot and its association with pathological characteristics of CRC patients was analyzed by chi-square test. Also, the expression of MIR4435-2HG, miR-125b-5p and Sema4D in CRC cell lines was detected by qRT-PCR and Western blot. Knockdown or overexpression of MIR4435-2HG, miR-125b- 5p and Sema4D were separately performed in Caco-2 and LoVo cells, and the cell propagation, migration and invasiveness were detected by cell-counting kit 8, scratch, and transwell assays.
Results. LncRNA MIR4435-2HG and Sema4D were highly expressed, while miR-125b-5p expression was decreased in CRC tissues and cells. Knockdown of MIR4435-2HG/Sema4D or overexpression of miR-125b-5p inhibited CRC cell proliferation and aggressiveness; overexpression of MIR4435-2HG/Sema4D or knockdown of miR-125b-5p prompted the malignant behaviors of cancer cells. MIR4435-2HG and Sema4D competitively bound to miR-125b-5p.
Conclusions. LncRNA MIR4435-2HG targets miR-125b-5p to upregulate Sema4D expression, and thus regulates CRC cell propagation, migration and invasiveness.

Article available in PDF format

View PDF Download PDF file

References

  1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3): 209–249.
  2. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424.
  3. Huang W, Sundquist J, Sundquist K, et al. Use of phosphodiesterase 5 inhibitors is associated with lower risk of colorectal cancer in men with benign colorectal neoplasms. Gastroenterology. 2019; 157(3): 672–681.e4.
  4. Tang Bo, Liang W, Liao Y, et al. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway. Oncol Rep. 2019; 41(1): 43–56.
  5. Kishore C, Bhadra P. Current advancements and future perspectives of immunotherapy in colorectal cancer research. Eur J Pharmacol. 2021; 893: 173819.
  6. Hong S, Yan Z, Wang H, et al. miR-663b promotes colorectal cancer progression by activating Ras/Raf signaling through downregulation of TNK1. Hum Cell. 2020; 33(1): 104–115.
  7. Deng X, Ruan H, Zhang X, et al. Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells. Int J Cancer. 2020; 146(6): 1700–1716.
  8. Jiang X, Zhu Q, Wu P, et al. Upregulated long noncoding RNA LINC01234 predicts unfavorable prognosis for colorectal cancer and negatively correlates with KLF6 expression. Ann Lab Med. 2020; 40(2): 155–163.
  9. Shang AQ, Wang WW, Yang YB, et al. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p. Am J Physiol Gastrointest Liver Physiol. 2019; 317(2): G222–G232.
  10. Wu M, Li W, Huang F, et al. Comprehensive analysis of the expression profiles of long non-coding RNAs with associated ceRNA network involved in the colon cancer staging and progression. Sci Rep. 2019; 9(1): 16910.
  11. Dong X, Yang Z, Yang H, et al. Long non-coding RNA MIR4435-2HG promotes colorectal cancer proliferation and metastasis through miR-206/YAP1 axis. Front Oncol. 2020; 10: 160.
  12. Wang L, Cho KB, Li Y, et al. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 2019; 20(22).
  13. Li C, Wang P, Du J, et al. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer. IUBMB Life. 2021; 73(1): 286–298.
  14. Liu Z, Gu Y, Cheng X, et al. Upregulation lnc-NEAT1 contributes to colorectal cancer progression through sponging miR-486-5p and activating NR4A1/Wnt/β-catenin pathway. Cancer Biomark. 2021; 30(3): 309–319.
  15. Zhang C, Yao K, Zhang J, et al. Long noncoding RNA MALAT1 promotes colorectal cancer progression by acting as a ceRNA of miR-508-5p to regulate RAB14 expression. Biomed Res Int. 2020; 2020: 4157606.
  16. Ding X, Qiu L, Zhang L, et al. The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer. Onco Targets Ther. 2016; 9: 1189–1204.
  17. Cao J, Zhang C, Chen T, et al. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion. J Dermatol Sci. 2015; 79(2): 127–136.
  18. Chen WG, Sun J, Shen WW, et al. Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer. Clin Exp Metastasis. 2019; 36(1): 39–56.
  19. Zhang C, Qiao H, Guo W, et al. CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis. Cancer Lett. 2019; 455: 1–13.
  20. Zhou S, Guo Z, Zhou C, et al. circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway. Cancer Cell Int. 2021; 21(1): 250.
  21. Cenariu D, Zimta AA, Munteanu R, et al. Hsa-miR-125b therapeutic role in colon cancer is dependent on the mutation status of the TP53 gene. Pharmaceutics. 2021; 13(5).
  22. Zhang J, Yang W, Xiao Y, et al. MiR-125b inhibits cell proliferation and induces apoptosis in human colon cancer SW480 cells via targeting STAT3. Recent Pat Anticancer Drug Discov. 2022; 17(2): 187–194.
  23. Shi H, Li K, Feng J, et al. LncRNA-DANCR interferes with miR-125b-5p/HK2 axis to desensitize colon cancer cells to cisplatin vis activating anaerobic glycolysis. Front Oncol. 2020; 10: 1034.
  24. Wang H, Wu M, Lu Y, et al. LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling. Aging (Albany NY). 2019; 11(17): 6657–6673.
  25. Yang M, He X, Huang X, et al. LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes migration and proliferation of nonsmall cell lung cancer cells. Environ Toxicol. 2020; 35(5): 582–590.
  26. Chen Y, Zhang L, Liu WX, et al. VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer. Cell Mol Biol Lett. 2018; 23: 2.
  27. Li H, Wang JS, Mu LJ, et al. Promotion of Sema4D expression by tumor-associated macrophages: significance in gastric carcinoma. World J Gastroenterol. 2018; 24(5): 593–601.
  28. Wang JS, Jing CQ, Shan KS, et al. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma. World J Gastroenterol. 2015; 21(7): 2191–2198.
  29. Wang Y, Zhao H, Zhi W. SEMA4D under the posttranscriptional regulation of HuR and miR-4319 boosts cancer progression in esophageal squamous cell carcinoma. Cancer Biol Ther. 2020; 21(2): 122–129.
  30. Xia Y, Cai XY, Fan JQ, et al. The role of sema4D in vasculogenic mimicry formation in non-small cell lung cancer and the underlying mechanisms. Int J Cancer. 2019; 144(9): 2227–2238.
  31. Ikeya T, Maeda K, Nagahara H, et al. The combined expression of Semaphorin4D and PlexinB1 predicts disease recurrence in colorectal cancer. BMC Cancer. 2016; 16: 525.
  32. Ren C, Xie R, Yao Y, et al. MiR-125b suppression inhibits apoptosis and negatively regulates Sema4D in avian leukosis virus-transformed cells. Viruses. 2019; 11(8).
  33. Hu T, Zhang Q, Gao L. LncRNA CAR10 upregulates PDPK1 to promote cervical cancer development by sponging miR-125b-5p. Biomed Res Int. 2020; 2020: 4351671.
  34. Park GB, Jeong JY, Kim D. Modified TLR-mediated downregulation of miR-125b-5p enhances CD248 (endosialin)-induced metastasis and drug resistance in colorectal cancer cells. Mol Carcinog. 2020; 59(2): 154–167.
  35. Park GB, Jeong JY, Kim D. GLUT5 regulation by AKT1/3-miR-125b-5p downregulation induces migratory activity and drug resistance in TLR-modified colorectal cancer cells. Carcinogenesis. 2020; 41(10): 1329–1340.
  36. Zhan W, Liao X, Chen Z, et al. LINC00858 promotes colorectal cancer by sponging miR-4766-5p to regulate PAK2. Cell Biol Toxicol. 2020; 36(4): 333–347.
  37. Shen MY, Zhou GR, -Y Zhang Z. LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis. Eur Rev Med Pharmacol Sci. 2020; 24(4): 1771–1777.
  38. Ouyang W, Ren L, Liu G, et al. LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer. PeerJ. 2019; 7: e6683.